Vaccination of cattle against B. Bovis infection with live attenuated parasites and non-viable immunogens

Vaccine

Volumn 26, Issue SUPPL.6, 2008, Pages

  Fish, Lea ^a   Leibovich, Benjamin ^a   Krigel, Yuri ^a   McElwain, Terry ^b   Shkap, Varda ^a  

^a KIMRON VETERINARY INSTITUTE   (Israel)

^b Washington Animal Disease Diagnostic Laboratory   (United States)

Author keywords

Babesia bovis; Live vaccine; Non viable antigens

Indexed keywords

LIVE VACCINE; PARASITE ANTIGEN; PROTOZOAL PROTEIN; PROTOZOAL VACCINE; PROTOZOON ANTIBODY; RECOMBINANT PROTEIN; RHOPTRY ASSOCIATED PROTEIN 1, BABESIA; RHOPTRY-ASSOCIATED PROTEIN-1, BABESIA;

ANIMAL; ANIMAL DISEASE; ARTICLE; BABESIA BOVIS; BABESIOSIS; BLOOD; CATTLE; CATTLE DISEASE; CLINICAL TRIAL; DAIRYING; GENETICS; IMMUNOLOGY; PARASITOLOGY; PATHOGENICITY; TREATMENT OUTCOME; VACCINATION;

ANIMALS; ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; BABESIA BOVIS; BABESIOSIS; CATTLE; CATTLE DISEASES; DAIRYING; PROTOZOAN PROTEINS; PROTOZOAN VACCINES; RECOMBINANT PROTEINS; TREATMENT OUTCOME; VACCINATION; VACCINES, ATTENUATED;

EID: 62849086835     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2008.09.070     Document Type: Article

References (37)

1. Bock RE, Jackson L, DeVos AJ, Jorgensen W. Babesiosis of cattle. Parasitology 2004;129:S247-69.
2. Mangold AJ, Vanzini VR, Echaide IE, De Echaide ST, Volpogni MM, Guglielmone AA. Viability after thawing and dilution of simultaneously cryopreserved vaccinal Babesia bovis and Babesia bigemina strains cultured in vitro. Vet Parasitol 1996;61(3-4):345-8.
3. DeWaal DT, CombrinkMP. Live vaccines against bovine babesiosis. Vet Parasitol 2006;138(1-2):88-96.
4. Shkap V, Leibovitz B, Krigel Y, Hammerschlag J, Marcovics A, Fish L, et al. Vaccination of older Bos taurus bulls against bovine babesiosis. Vet Parasitol 2005;129(3-4):235-42.
5. Bock RE, DeVos AJ, Kingston TC, Sheils IA, Dalgliesh RJ. Investigations of breakdowns in protection provided by living Babesia bovis vaccine. Vet Parasitol 1992;43(1-2):45-56.
6. Bock RE, DeVos AJ, Lew AE, Kingston TJ, Fraser IR. Studies of failure of T strain live Babesia bovis vaccine. Aust Vet J 1995;72(8):296-300.
7. DeVos AJ. Immunogenicity and pathogenicity of three South African strains of Babesia bovis in Bos indicus cattle. Onderstepoort J Vet Res 1978;45:119-24.
8. Buening GM, Kuttler KL, Rodriguez SD. Evaluation of a cloned Babesia bovis organism as a live immunogen. Vet Parasitol 1986;22(3-4):235-42.
9. Pipano E, Fish L, Frank M, Shkap V, Krigel Y. Virulence and immunogenicity of in vitro clones of Babesia bovis. J Protozool 1991;38(suppl):101.
10. Timms P, Stewart NP, Rodwell BJ, Barry DN. Immune responses of cattle following vaccination with living and non-living Babesia bovis antigens. Vet Parasitol 1984;16(3-4):243-51.
11. Montenegro-James S, Ristic M, Benitez T, Leon E, Lopez R. Heterologous strain immunity in bovine babesiosis using a culture-derived soluble Babesia bovis immunogen. Vet Parasitol 1985;18(4):321-7.
12. Pattarroyo JH, Prates AA, Tavares CA, Mafra CL, Vargas MI. Exoantigens of an attenuated strain of Babesia bovis used as a vaccine against bovine babesiosis. Vet Parasitol 1995;59(3-4):189-99.
13. Wright IG, Casu R, Commins MA, Dalrymple BP, Gale KR, Goodger BV, et al. The development of recombinant Babesia vaccine. Vet Parasitol 1992;44(1-2):3-13.
14. Norimine J, Mosqueda J, Suarez C, Palmer GH, McElwain TF, Mbassa G, et al. Stimulation of T-helper cell gamma interferon and immunoglobulin G responses specific for Babesia bovis rhoptry-associated protein 1 (RAP-1) or a RAP-1 protein lacking the carboxy-terminal repeat region is insufficient to provide protective immunity against virulent B. bovis challenge. Infect Immun 2003;71(9):5021-32.
15. Brown WC, Norimine J, GoffWL, Suarez CE, McElwain TF. Prospects for recombinant vaccines against Babesia bovis and related parasites. Parasit Immunol 2006;28(7):315-27.
16. CallowLL, Merrors LT,McGregorW. Reduction in virulence of Babesia bovis due to rapid passage in splenectomized cattle. Int J Parasitol 1979;9(4):333-8.
17. Ristic M, Levy MG. A newera of research towards solution of bovine babesiosis. In: Ristic MG, Krier JP, editors. Babesiosis. New York: Academic Press; 1981. p. 501-44.
18. Levy MG, Ristic M. Babesia bovis: continuous cultivation in a microaerophilous stationary phase culture. Science 1980;207(4436):1218-20.
19. Rodriguez SD, Buening GM, Green TJ, Carson CA. Cloning of Babesia bovis by in vitro cultivation. Infec Immun 1982;42(1):15-8.
20. Goldman M, Pipano E, Rosenberg AS. Fluorescent antibody tests for Babesia bigemina and Babesia berbera. Res Vet Sci 1972;13(1):77-81.
21. Pipano E, Krigel Y, Marcovics A, Rubinshtein E, Frank M. Mitigation of the response of Friesian calves to live Babesia bovis vaccine by treatment with long-acting oxytetracycline. Vet Rec 1985;117:413-4.
22. Shkap V, Pipano E. Culture-derived parasites in vaccination of cattle against tick-borne diseases. Ann NY Acad Sci 2000;916:154-71.
23. Shkap V, DeVos AJ, Zweygarth E, Jongejan F. Attenuated vaccines for tropical theileriosis, babesiosis and heartwater: the continuing necessity. Trends Parasitol 2007;23(9):420-6.
24. Timms R, Dalgliesh RJ, Barry DN, Dimmock CK, Rodwell BJ. Babesia bovis: comparison of culture-derived parasites, non-living antigen and conventional vaccine in the protection of cattle against heterologous challenge. Aust Vet J 1983;60(3):75-7.
25. Lew AE, Bock RE, Croft JM, Minchin CM, Kingston TG, Galgliesh RJ. Genotypic diversity in field isolates of Babesia bovis from cattle with babesiosis after vaccination. Aust Vet J 1997;75(8):575-8.
26. Brown WC, Norimine J, Knowles DP, GoffWL. Immune control of Babesia bovis infection. Vet Parasitol 2006;138(1-2):75-87.
27. Hines SA, Palmer GH, Jasmer DP, McGuire TC, McElwain TF. Neutralizationsensitive merozoite surface antigens of Babesia bovis encoded bymembers of a polymorphic gene family. Mol Biochem Parasitol 1992;55(1-2):85-94.
28. Hines SA, Palmer GH, Jasmer DP, Goff WL, McElwain TF. Immunization of cattle with recombinant Babesia bovis merozoite surface antigen-1. Infect Immun 1995;63(1):349-52.
29. Brown WC. Molecular approaches to elucidation of innate and acquired immune responses to the protozoan parasite Babesia bovis that causes persistent infection. Vet Parasitol 2001;101(3-4):233-48.
30. Wilkowsky SE, Farber M, Echaide I, Torioni de Echaide S, Zamorano PI, Dominguez M, et al. Babesia bovis merozoite surface protein-2c (MSA-2c) contains highly immunogenic, conserved B-cell epitopes that elicit neutralizationsensitive antibodies in cattle. Mol Biochem Parasitol 2003;127(2):133- 41.
31. Mosqueda J, McElwain, Stiller D, Palmer GH. Babesia bovis merozoite surface antigen 1 and rhoptry-associated protein 1 are expressed in sporozoites and specific antibodies inhibit sporozoite attachment to erythrocytes. InfectImmun 2002;70(3):1599-603.
32. Mosqueda J, McElwain TF, Palmer GH. Babesia bovis merozoite surface antigen 2 proteins are expressed on the merozoite and sporozoite surface, and specific antibodies inhibit attachment and invasion of erythrocytes. Infect Immun 2002;70(11):6448-55.
33. Yokoyama N, Suthisak B, Hirata H,Matsuo T, Inoue N, Sugimoto C, et al. Cellular localization of Babesia bovis rhopthy-associated protein 1 and its erythrocytebinding activity. Infect Immun 2002;70(10):5822-6.
34. Morzaria S, Nene V, Bishop R, Musoke A. Vaccines against Theileria parva. Ann NY Acad Sci 2000;916:464-73.
35. Egan AF, Burghaus P, Druilhe P, Holder AA, Riley EM. Human antibodies to the 19-kDa C-terminal fragment of Plasmodium falciparum merozoite surface protein 1 inhibit parasite growth in vitro. Parasit Immunol 1999;21(3): 133-9.
36. Lopez OJ, Osorio FA. Role of neutralizing antibodies in PRRSV protective immunity. Vet Immunol Immunopathol 2004;102(3):155-63.
37. Bisht H, Roberts A, Vogel L, Subbarao K, Moss B. Neutralizing antibody and protective immunity to SARS coronavirus infection of mice induced by a soluble recombinant polypeptide containing an N-terminal segment of the spike glycoprotein. Virology 2005;334(2):160-5.